TUESDAY, June 29, 2021 (HealthDay News) — People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those outcomes, new research shows. The clinical trial was conductedContinue Reading

TUESDAY, June 29, 2021 (HealthDay News) — Hospitalized patients with diabetes who hadn’t been taking their medication had more severe cases of COVID-19, a new study shows. “Our results highlight the importance of assessing, monitoring and controlling blood glucose [sugar] in hospitalized COVID-19 patients from the start,” said study authorContinue Reading

TUESDAY, June 1, 2021 (HealthDay News) — An aggressive weight-loss program not only achieves remission of type 2 diabetes, but may also end the need for blood pressure medications, new research shows. “Our study shows that, in addition to possible remission from type 2 diabetes, there are other very importantContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — Researchers have discovered that when patients who have type 2 diabetes and asthma take a certain class of medication to control their blood sugar, their asthma symptoms also improved. Not only could this help diabetes patients who may have less asthma control onContinue Reading

MONDAY, May 17, 2021 (HealthDay News) — Though obesity by itself can drive up heart disease risk, new research suggests diabetes and heart disease risk is especially high when combined with a tendency to stay up late at night. The finding stems from a comparison of sleep patterns and diseaseContinue Reading